Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).
about
Nodal expression and detection in cancer: experience and challengesESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer.Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineCan biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Tumour heterogeneity in the clinic.St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.Heterogeneity of estrogen receptor expression in circulating tumor cells from metastatic breast cancer patientsLuminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cellsClinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studiesComparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor lossPreclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer.Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patientsNT5E CpG island methylation is a favourable breast cancer biomarker.Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series.Human epidermal growth factor receptor 2 protein expression between primary breast cancer and paired asynchronous local-regional recurrences.Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.Biopsy of breast cancer metastases: patient characteristics and survivalPotential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancerOrgan-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes.Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.Breast Cancer: State of the Art and New Findings.Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer.Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implicationsER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases.14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers.Par(-4)oxysm in breast cancer.Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomesProspective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer
P2860
Q27024576-5FF4A979-6153-46F7-8426-50BDCCE84585Q30317067-BBF5EA4D-BA72-4EE7-B790-FA1339F2F2E6Q30317569-4ED7CB5D-60BA-4C0A-8F0C-5C597E9C4EAEQ30318823-1912CAFC-BE9A-4436-922A-905E132BB1B7Q31006508-B2367D30-A1FB-42C7-8C84-8C73C30C3153Q33699614-EC0ED77A-D5CC-4AD6-820B-25EA23BBD93AQ33738675-7F1118D5-A3F5-4722-BD40-0E8DAF61B2A1Q33768759-86972507-C69E-4624-BFD6-D173B1191C2AQ33777431-748144A2-AA59-4BC1-9300-D3B816EE21D1Q33817285-109EAE12-403F-44CE-8B60-C4E6BD50E298Q33820233-C3C767C7-8C6B-4575-9341-1B20F51E87E1Q34372080-6840E5A4-ACC7-4BF5-B136-004780036C06Q34463987-DD757391-A474-4D3F-ACF7-13BD2DC98466Q34723641-D788A752-8C23-4835-B5FC-1D535815855BQ34994963-0D479A15-F804-4876-B85B-8E5C216C17ADQ35000639-80ADDA05-2008-4E9E-893E-6C78564C15F3Q35016088-A216950B-80D0-438D-B6BC-CD45AE6D4512Q35082619-3591FDB3-2767-46F9-B379-33DA38D26491Q35558909-7EF6DB6F-1723-4FD5-B284-3E4BE7B94EA7Q35808400-5798AB83-6618-40DF-96C7-B45A4E6D8B0CQ35927942-E96566C4-FE80-4890-9103-9DF0C5FA61B4Q36075236-75544972-E536-4AC4-9A5F-9A85957943B6Q36085375-25577599-90B0-4F19-A9B1-4719A30318B5Q36107363-BE0266C5-A334-4866-9765-9B495CAAD65FQ36138028-AA44571C-8F1C-426F-9343-D83E8C3568DEQ36230879-72D4C680-7CAA-4C9C-AF95-ECD1883013A0Q36236032-ABAABB01-9AD5-4A49-8D01-52EC43E86305Q36239768-9D31D2F0-2F5E-4F51-9689-77C217FA765EQ36245363-6E4FD84F-32C9-47A8-A818-B35F479C0019Q36266131-444A2844-1A47-4D94-B40C-1E5E96430BD8Q36292201-60382C4D-0360-4755-BA8D-C75CD3B43D12Q36295112-A882F10B-D350-4723-B2FC-EB981A7315F0Q36471883-ED182824-7290-4DE0-9FB3-23BBD4B70DBFQ36525788-43B68832-736B-4021-AB64-C3A85B156813Q36545146-6DC1F74F-3D30-424D-AA39-4C2DB155A139Q36629859-BBD8AEF3-CDBB-4D98-B517-95E081B7D502Q36784639-969B8932-AF5C-4FED-B4D8-4053B05984D3Q37094811-0CB6EEFC-1B24-45FC-A112-D6F0D5A1D6ABQ37174919-F441B194-506B-4EB2-B975-3D9731811AC9Q37240839-0B4C4647-F1EE-4E00-A490-EFB3EE22F841
P2860
Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@ast
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@en
Prospective comparison of swit ...... st Recurrence In Tissues Study
@nl
type
label
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@ast
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@en
Prospective comparison of swit ...... st Recurrence In Tissues Study
@nl
prefLabel
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@ast
Prospective comparison of swit ...... ence In Tissues Study (BRITS).
@en
Prospective comparison of swit ...... st Recurrence In Tissues Study
@nl
P2093
P2860
P356
P1476
Prospective comparison of swit ...... rence In Tissues Study (BRITS)
@en
P2093
Alastair M Thompson
Anthony Skene
Breast Recurrence in Tissues Study Group
Elizabeth Anderson
John A Dewar
Lee B Jordan
P2860
P2888
P356
10.1186/BCR2771
P577
2010-11-08T00:00:00Z
P5875
P6179
1030436418